LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Search

Omnicell Inc

Fechado

SetorSaúde

36.6 -1.05

Visão Geral

Variação de preço das ações

24h

Atual

Mín

36.38

Máximo

37.28

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

84.279

79.874

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+10.94% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

262M

1.7B

Abertura anterior

37.65

Fecho anterior

36.6

Sentimento de Notícias

By Acuity

50%

50%

168 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de nov. de 2025, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 de nov. de 2025, 15:32 UTC

Aquisições, Fusões, Aquisições de Empresas

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 de nov. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 de nov. de 2025, 23:50 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de nov. de 2025, 16:05 UTC

Conversa de Mercado

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 de nov. de 2025, 16:04 UTC

Conversa de Mercado

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 de nov. de 2025, 15:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 de nov. de 2025, 15:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 de nov. de 2025, 15:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 de nov. de 2025, 15:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 de nov. de 2025, 15:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 de nov. de 2025, 15:11 UTC

Conversa de Mercado

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 de nov. de 2025, 14:26 UTC

Conversa de Mercado

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 de nov. de 2025, 14:11 UTC

Conversa de Mercado

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 de nov. de 2025, 14:11 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

27 de nov. de 2025, 13:35 UTC

Conversa de Mercado

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 de nov. de 2025, 13:33 UTC

Conversa de Mercado

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 de nov. de 2025, 13:22 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

27 de nov. de 2025, 13:22 UTC

Conversa de Mercado

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 de nov. de 2025, 13:17 UTC

Conversa de Mercado

LVMH Should Be Able to Recover Next Year -- Market Talk

27 de nov. de 2025, 11:13 UTC

Conversa de Mercado

European Gas Prices Come Under Pressure -- Market Talk

27 de nov. de 2025, 11:07 UTC

Ganhos

Genting: Positive About Prospects Over Longer Term

27 de nov. de 2025, 11:06 UTC

Ganhos

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: International Travel Demand Expected to Remain Resilient

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: Global Growth Expected to Remain Subdued

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 de nov. de 2025, 10:59 UTC

Ganhos

Genting Bhd 3Q Net Profit Fell 86% on Year

27 de nov. de 2025, 10:58 UTC

Ganhos

Genting Bhd 3Q Rev Rose 14% on Year

27 de nov. de 2025, 10:56 UTC

Ganhos

Genting Bhd 3Q Net MYR30.3M

27 de nov. de 2025, 10:56 UTC

Ganhos

Genting Bhd 3Q EPS MYR0.0079

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

10.94% parte superior

Previsão para 12 meses

Média 40.67 USD  10.94%

Máximo 45 USD

Mínimo 34 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

168 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat